GeneBioTech Co. Ltd (086060) — Cash Flow Quality Index
GeneBioTech Co. Ltd (086060) has a Cash Flow Quality Index of 3.92x as of September 2025. Operating cash flow of ₩3.87 Billion exceeds net income of ₩986.50 Million, indicating high earnings quality where cash backs reported profits. Explore GeneBioTech Co. Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GeneBioTech Co. Ltd Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for GeneBioTech Co. Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GeneBioTech Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for GeneBioTech Co. Ltd (2009–2024)
Year-by-year earnings quality comparison for GeneBioTech Co. Ltd. For live market cap and the full company financial profile, see 086060 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.16x | ₩-463.87 Million | ₩2.87 Billion | ▼ -105.7% |
| 2023 | 2.84x | ₩7.37 Billion | ₩2.59 Billion | ▲ +217.7% |
| 2022 | -2.42x | ₩-3.68 Billion | ₩1.52 Billion | ▲ +23.7% |
| 2019 | -3.17x | ₩-2.68 Billion | ₩846.78 Million | ▼ -242.7% |
| 2018 | 2.22x | ₩5.96 Billion | ₩2.68 Billion | ▲ +309.5% |
| 2017 | 0.54x | ₩1.13 Billion | ₩2.09 Billion | ▼ -74.1% |
| 2016 | 2.10x | ₩5.31 Billion | ₩2.53 Billion | ▼ -53.0% |
| 2015 | 4.46x | ₩2.61 Billion | ₩583.71 Million | ▲ +125.9% |
| 2014 | 1.98x | ₩2.15 Billion | ₩1.09 Billion | ▼ -83.1% |
| 2013 | 11.66x | ₩2.38 Billion | ₩203.94 Million | ▲ +152.7% |
| 2011 | 4.61x | ₩2.53 Billion | ₩547.78 Million | ▲ +322.2% |
| 2010 | 1.09x | ₩1.17 Billion | ₩1.07 Billion | ▼ -71.0% |
| 2009 | 3.77x | ₩2.68 Billion | ₩711.60 Million | — |